The Scientific Advisory Team at GABA Therapeutics comprises esteemed experts who provide critical insights and guidance on the development of GRX-917. They collaborate with the research and clinical teams to ensure the scientific rigor of preclinical and clinical studies, help shape the strategic direction of the product's development, and contribute to regulatory engagement, ultimately aiming to enhance the safety and efficacy profiles of treatments for anxiety and depression.
View all